Thanks Stotes. So looks like retail patience has given up, and...

Thanks Stotes. So looks like retail patience has given up, and instos are accumulating. For me the key is a positive study with the Carrick institute. Without this I'm not sure how the sales team can sell the product with conviction. If the study gets a thumbs up, then the distributors will be set. I read that to get a 501(k) submission cleared it takes an average 177 days. In the mean time they could sell in Europe, then once FDA clears the device expand to North America, which looks like the plan. I have asked investor relations if anything further to an initial meeting has been had, and the timeline for FDA.

Cash burn wasn't too bad, and I expect they will get an R & D rebate at some point in the future.

What were your thoughts on the 4C?